OncoSec Closes $7.75 Million Public Offering
OncoSec intends to use proceeds from the offering for general corporate purposes, including clinical trial expenses and research and development expenses.
feature2
The 4 Small Diabetes Diagnostics Companies You Overlooked
Some experts believe large pharmaceutical companies have reached a plateau in market growth. However, that doesn’t tell the whole story, as new companies with disruptive technology have made some significant advancements in 2012.
How Crowdfunding Affects the Healthcare Market, and Your Wallet
Unlike technology, entertainment, retail and other sectors, novel medical technologies and therapeutics take years of pre-development, and require institutional manpower to further growth.
Advaxis Nominated for Vaccine Industry Excellence Award
The company has been selected for the shortlist of the 5th Annual Vaccine Industry Excellence (ViE) Awards in the category of Best Therapeutic Vaccine.
FDA’s Farm Animal Antibiotics Ban Ignored Since 1977, Courts Say
The Food and Drug Administration must act quickly to enforce a largely ignored 35-year-old mandate prohibiting non-medical use of antibiotics in farm animals.
CS-131: One of the Most Significant Advancements in Brachytherapy
Brachytherapy, a form of radiation therapy where radioactive seeds – or isotopes – are placed near or inside the tumor to emit radiation, is one of the most intriguing both in the medical and investor community.
Crowdfunding: Politicians Love the JOBS Act, Why Investors May Not
Despite political contention over the influence of corporate America in shaping the American Dream, our nation’s leaders tend to unite in their respect of small business.
Diagnostics in South Asia
India, the world’s largest democracy, has seen dramatic changes in diagnostic developments. The Hindu, a daily newspaper focusing on India and abroad, reported that India has the highest number of multidrug-resistant TB in South East Asia.
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
The Magazine For Decision Makers in a Global Industry Launches in NYC
New Pharma Magazine celebrated the launch of the first edition in New York City last week by partnering with the Drug Chemical and Associated Technologies Association.